Sumitomo Mitsui Trust Group, Inc. 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-04 06:13 am Sale |
2024-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
Sumitomo Mitsui Trust Group, Inc. | 6,833,137 4.600% |
-900,747 (-11.65%) |
Filing |
| 2024-11-05 06:07 am Purchase |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
Sumitomo Mitsui Trust Group, Inc. | 7,733,884 5.240% |
7,733,884 (New Position) |
Filing |